Glycemic and Cost Outcomes among Hispanic/Latino People with Type 2 Diabetes in the USA Initiating Dulaglutide versus Basal Insulin: a Real-World Study

被引：0
|
作者：
Meredith Hoog
Juan M. Maldonado
Ruth Wangia-Dixon
Rachel Halpern
Erin Buysman
Garrett W. Gremel
Ahong Huang
Manige Konig
机构：
[1] Eli Lilly and Company,
[2] Lilly Corporate Center,undefined
[3] Eli Lilly Export S.A.,undefined
[4] Optum Inc.,undefined
[5] Tigermed-BDM,undefined
来源：
Diabetes Therapy | 2024年 / 15卷
关键词：
Dulaglutide; Glycated hemoglobin; Glucagon-like peptide-1 receptor; Hispanic/Latino; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：855 / 867
页数：12
相关论文
共 50 条
  • [31] iGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real-world study
    Lajara, Rosemarie
    Heller, Caroline
    Pantalone, Kevin M.
    Lew, Elisheva
    Li, Xuan
    Dex, Terry
    Kilpatrick, Catherine Rachel
    DIABETES OBESITY & METABOLISM, 2023, 25 (05): : 1249 - 1260
  • [32] A real-world analysis of glycemic control among patients with type 2 diabetes treated with canagliflozin versus dapagliflozin
    Blonde, Lawrence
    Patel, Charmi
    Bookhart, Brahim
    Pfeifer, Michael
    Chen, Yen-Wen
    Wu, Bingcao
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (06) : 1143 - 1152
  • [33] Effects of basal and premixed insulin on glycemic control in type 2 diabetes patients based on multicenter prospective real-world data
    Peng, Ying
    Xu, Peihong
    Shi, Juan
    Zhang, Yifei
    Wang, Shujie
    Zheng, Qidong
    Wang, Yufan
    Ke, Tingyu
    Li, Li
    Zhao, Dong
    Dai, Yuancheng
    Dong, Qijuan
    Ji, Bangqun
    Xu, Fengmei
    Gu, Weiqiong
    Wang, Weiqing
    JOURNAL OF DIABETES, 2022, 14 (02) : 134 - 143
  • [34] Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study
    Ragonese, Mauro
    Larosa, Monica
    Angotti, Stefania
    Annese, Stefania
    Cruciani, Laura
    Dainelli, Michela
    Lucisano, Giuseppe
    Prosperini, Giuseppe
    Sacco, Michele
    Salomone, Enrica
    Saponara, Caterina
    Semprini, Roberta
    Rossi, Maria Chiara
    Nicolucci, Antonio
    DIABETES THERAPY, 2020, 11 (10) : 2283 - 2298
  • [35] Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study
    Mauro Ragonese
    Monica Larosa
    Stefania Angotti
    Stefania Annese
    Laura Cruciani
    Michela Dainelli
    Giuseppe Lucisano
    Giuseppe Prosperini
    Michele Sacco
    Enrica Salomone
    Caterina Saponara
    Roberta Semprini
    Maria Chiara Rossi
    Antonio Nicolucci
    Diabetes Therapy, 2020, 11 : 2283 - 2298
  • [36] iGlarLixi versus basal plus Rapid-Acting insulin in adults with type 2 diabetes advancing from basal insulin therapy: The SoliSimplify Real-World study
    McCrimmon, Rory J.
    Cheng, Alice Y. Y.
    Galstyan, Gagik
    Djaballah, Khier
    Li, Xuan
    Coudert, Mathieu
    Frias, Juan P.
    DIABETES OBESITY & METABOLISM, 2023, 25 (01): : 68 - 77
  • [37] A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes
    Miyoshi, Hideaki
    Baxter, Mike
    Kimura, Takeshi
    Hattori, Masakatsu
    Morimoto, Yukiko
    Marinkovich, Dion
    Tamiwa, Masami
    Hirose, Takahisa
    DIABETES THERAPY, 2021, 12 (05) : 1341 - 1357
  • [38] REAL-WORLD INSULIN TREATMENT PERSISTENCE AMONG PATIENTS WITH TYPE 2 DIABETES: MEASURES, PREDICTORS, AND OUTCOMES
    Wei, Wenhui
    Pan, Chunshen
    Xie, Lin
    Baser, Onur
    ENDOCRINE PRACTICE, 2014, 20 (01) : 52 - 61
  • [39] A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes
    Hideaki Miyoshi
    Mike Baxter
    Takeshi Kimura
    Masakatsu Hattori
    Yukiko Morimoto
    Dion Marinkovich
    Masami Tamiwa
    Takahisa Hirose
    Diabetes Therapy, 2021, 12 : 1341 - 1357
  • [40] REAL-WORLD OUTCOMES OF INITIATING TWO DIFFERENT BASAL INSULIN THERAPIES VIA DISPOSABLE PENS AMONG PATIENTS WITH TYPE 2 DIABETES IN US EMPLOYER-SPONSORED HEALTH PLANS
    Du, J.
    Wei, W.
    Xie, L.
    Pan, C.
    Baser, O.
    VALUE IN HEALTH, 2011, 14 (07) : A476 - A476
12345